Tag Archives: Bayer

December, 2018

November, 2018

October, 2018

August, 2018

May, 2018

December, 2017

November, 2017

  • 20 November

    Bayer Enters Potential Billion-Dollar Discovery Collaboration Agreement with PeptiDream

    KAWASAKI, Japan–(BUSINESS WIRE)–PeptiDream Inc., a public Kanagawa-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that it has entered into a multi-target discovery collaboration with Germany-based Bayer AG (“Bayer”)(ETR:BAYN). Under the agreement, PeptiDream will use its proprietary Peptide Discovery Platform System (PDPS) technology to identify macrocyclic/constrained peptides against multiple targets of interest selected …

  • 15 November

    Bayer and Loxo Oncology to Co-Develop Cancer Drugs in up to $1.55 Billion Deal

    WHIPPANY, N.J., Nov. 14, 2017 /PRNewswire/ — Bayer announced today that the company has entered into an exclusive global collaboration with Loxo Oncology, Inc., a biopharmaceutical company based in Stamford, Connecticut (NASDAQ: LOXO) for the development and commercialization of larotrectinib (LOXO-101) and LOXO-195. Both compounds are being investigated in global …

October, 2017

September, 2017